Recent work on neurotrophin levels in diseases of the brain have indicated that reduced neurotrophin levels (BNDF and glial derived neurotrophic factor – GDNF) correlate with the onset of neurodegenerative disorders such as Parkinson’s disease, AD, and HD (reviewed in Allen et al., 2013). This evidence concerns the gene BDNF and brain disorder.